175 related articles for article (PubMed ID: 6182407)
1. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
Fiedler VB; Mardin M
Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579
[TBL] [Abstract][Full Text] [Related]
3. Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.
Jouve R; Puddu PE; Langlet F; Guillen JC; Gautier T; Cano JP; Serradimigni A
J Pharmacol; 1985; 16(2):139-57. PubMed ID: 3903352
[TBL] [Abstract][Full Text] [Related]
4. Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart.
Kowey PR; Verrier RL; Lown B
Eur J Pharmacol; 1982 May; 80(1):83-91. PubMed ID: 7047179
[TBL] [Abstract][Full Text] [Related]
5. The influence of prostacyclin on coronary occlusion induced arrhythmia in cats.
Dix RK; Kelliher GJ; Jurkiewicz N; Lawrence T
Prostaglandins Med; 1979 Sep; 3(3):173-84. PubMed ID: 399533
[TBL] [Abstract][Full Text] [Related]
6. Effects of prostacyclin on systemic and coronary hemodynamics in the dog.
Mehta J; Nichols WW; Mehta P; Pepine C; Conti CR
Am Heart J; 1981 Nov; 102(5):835-40. PubMed ID: 7030040
[TBL] [Abstract][Full Text] [Related]
7. Influence of prostacyclin on coronary thrombosis and myocardial ischemia in conscious canine experiments.
Fiedler VB; Mardin M
Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):114-27. PubMed ID: 3913392
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
Firth BG; Winniford MD; Campbell WB; Hillis LD
Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
[TBL] [Abstract][Full Text] [Related]
9. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
Aiken JW; Shebuski RJ
Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic responses to prostacyclin (PGI2) in the conscious sheep.
Kubo K; Kobayashi T; Yoshimura K; Fukushima M; Handa K; Kusama S; Sakai A; Ueda G
Jpn Circ J; 1982 Dec; 46(12):1292-304. PubMed ID: 6754986
[TBL] [Abstract][Full Text] [Related]
11. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
[TBL] [Abstract][Full Text] [Related]
12. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandins and cyclic nucleotides: effects of PGI2 and PGE1 on cardiac hemodynamic and coronary arterial and myocardial cyclic nucleotide levels in dogs.
Ito T; Ogawa K; Enomoto I; Hashimoto H; Kai I; Sakai K; Satake T
Jpn Circ J; 1980 Sep; 44(9):755-61. PubMed ID: 6251292
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
Warrington SJ; Smith PR; O'Grady J
Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
[TBL] [Abstract][Full Text] [Related]
15. Molsidomine prevents post-ischaemic ventricular fibrillation in dogs.
Cano JP; Guillen JC; Jouve R; Langlet F; Puddu PE; Rolland PH; Serradimigni A
Br J Pharmacol; 1986 Aug; 88(4):779-89. PubMed ID: 3755634
[TBL] [Abstract][Full Text] [Related]
16. Systemic and coronary hemodynamic effects of prostacyclin and nitroprusside in conscious dogs.
Dinerman J; Mehta JL; Nichols WW
J Cardiovasc Pharmacol; 1988 Oct; 12(4):492-6. PubMed ID: 2465452
[TBL] [Abstract][Full Text] [Related]
17. The orally active thia-imino-prostacyclin Hoe 892: antiaggregatory and cardiovascular activities.
Schölkens BA; Gehring D; Jung W
Prostaglandins Leukot Med; 1983 Mar; 10(3):231-56. PubMed ID: 6405394
[TBL] [Abstract][Full Text] [Related]
18. Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog hearts.
Scholtholt J; Birringer H; Fiedler VB; Schölkens B
Basic Res Cardiol; 1981; 76(3):313-27. PubMed ID: 7023464
[TBL] [Abstract][Full Text] [Related]
19. The influence of prostacyclin on hemodynamic and coronary blood flow in dogs.
Teesalu R; Kòrgevee A
Biomed Biochim Acta; 1988; 47(10-11):S56-9. PubMed ID: 3073770
[TBL] [Abstract][Full Text] [Related]
20. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
